Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (221-230 of 287) with videos related to

Pageof 29
Sort By:
Pediatric Blood & Cancer|July 10, 2021
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031Sarah A Milgrom, Jihyun Kim, Alin Chirindel, et al.
Blood Cancer Journal|August 22, 2022
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapyKelsey M Frechette, Scott C Lester, Kekoa Taparra, et al.
Cancers|October 28, 2023
Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and ChondrosarcomasAdam L Holtzman, Katharina Seidensaal, Alberto Iannalfi, et al.
Cancer|January 3, 2014
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancerBradford S Hoppe, Jeff M Michalski, Nancy P Mendenhall, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2023
Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudyJames E Bates, Suman Shrestha, Qi Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2020
Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group GuidelinesAndrew Wirth, N George Mikhaeel, Berthe M P Aleman, et al.
Pageof 29

Showing results (221-230 of 287) with videos related to

Sort By:
Pageof 29
Pediatric Blood & Cancer|July 10, 2021
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031Sarah A Milgrom, Jihyun Kim, Alin Chirindel, et al.
Blood Cancer Journal|August 22, 2022
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapyKelsey M Frechette, Scott C Lester, Kekoa Taparra, et al.
Cancers|October 28, 2023
Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and ChondrosarcomasAdam L Holtzman, Katharina Seidensaal, Alberto Iannalfi, et al.
Cancer|January 3, 2014
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancerBradford S Hoppe, Jeff M Michalski, Nancy P Mendenhall, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2023
Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudyJames E Bates, Suman Shrestha, Qi Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2020
Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group GuidelinesAndrew Wirth, N George Mikhaeel, Berthe M P Aleman, et al.
Pageof 29